Navigation Links
VIVUS to Present at Four Upcoming Investor Conferences
Date:9/10/2010

MOUNTAIN VIEW, Calif., Sept. 10 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that VIVUS management will present an overview of the company at four investment conferences during the month of September.  The conference presentation schedule is as follows:Bank of America Merrill Lynch Global Healthcare Conference Presented by: Timothy Morris, chief financial officerSeptember 16, 2010 at 2:30 p.m. BST Bank of America Merrill Lynch Financial Centre, London, UKStifel Nicolaus 2010 Healthcare ConferencePresented by: Dr. Wesley Day, vice president, clinical development September 17, 2010 at 9:45 a.m. EDTFour Seasons, Boston, MAUBS Global Life Sciences ConferencePresented by: Timothy Morris, chief financial officerSeptember 22, 2010 at 12:30 p.m. EDTThe Grand Hyatt, New York, NYThe Fifth Annual JMP Securities Healthcare ConferencePresented by: Timothy Morris, chief financial officerSeptember 28, 2010 at 8:30 a.m. EDTThe Palace Hotel, New York, NYA live audio webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and an NDA has been filed and accepted by the FDA, with an action date of October 28, 2010. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. MUSE® (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information a
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VIVUS to Present at Two Upcoming Investor Conferences
2. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
3. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
4. VIVUS to Present at Four Upcoming Healthcare Conferences
5. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
6. VIVUS to Present at the Needham and Company Life Sciences Conference
7. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
8. VIVUS Reports First Quarter 2009 Financial Results and Highlights
9. Paratek to Present Clinical Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. Lexicon to Present at Stifel Nicolaus Healthcare Conference
11. WaferGen Corporate Presentation to be Webcast at Rodman and Renshaws 12th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... light, developed by researchers at the University of Cambridge, ... the realm of science fiction, such as invisibility cloaks ... be a reality for quite some time, the technique ... blocks a few billionths of a metre across can ... through them, and works on large chunks all at ...
(Date:7/28/2014)... 2014 According to a new ... "Regenerative Medicine (Bone and Joint) Market (By Technology ... By Applications - Bone Graft Substitutes, Osteoarticular Diseases, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, ... and joint) market was valued at USD 2.6 ...
(Date:7/28/2014)... According to the ... Instruments, Services), Methods (Phenotypic, Genotypic), Applications (Pharmaceutical, Diagnostic, Environmental, ... - Global Forecasts to 2019" published by ... at $896.5 Million in 2014 and is ... growing at a CAGR of 5.9% from ...
(Date:7/28/2014)... Louis, MO (PRWEB) July 28, 2014 ... software, and services that bring the power of genomics ... the inaugural Appistry Pipeline Challenge . , ... Bell, president of the National Center for Genome Resources, ... Mercy Hospitals and Clinics of Kansas City. Rounding out ...
Breaking Biology Technology:Building 'invisible' materials with light 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2
... Neptune Technologies ... in FUNCTIONAL FOOD market-- LAVAL, ... (NASDAQ.NEPT - TSX.V.NTB) reported today,that it entered a worldwide alliance ... Weider Global Nutrition for the distribution,of dietary supplements and functional ...
... 25 Osteotech, Inc.,(Nasdaq: OSTE ), a leader ... announced today the appointment of Cato T.,Laurencin, M.D., Ph.D. ... of Directors effective September 24, 2008 and will serve ... Board of Directors., Kenneth P. Fallon, III, Chairman ...
... 25 Vermillion, Inc.,(Nasdaq: VRML ), a ... notification from The NASDAQ Stock Market LLC that ... the Company,s,securities from The NASDAQ Capital Market, effective ... 25, 2008. The delisting is the result of,the ...
Cached Biology Technology:Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 3Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 4Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2Vermillion Announces Receipt of NASDAQ Panel Decision 2Vermillion Announces Receipt of NASDAQ Panel Decision 3
(Date:7/29/2014)... genetics company, has received from the National Institutes ... a two-year project to support the further development ... genetic discovery. , Specifically, the grant supports ... web-based surveys to improve the company,s ability to ... survey tools to support the collection of a ...
(Date:7/29/2014)... There,s some good news for parents of preterm babies ... that by the time they become teenagers, the brains of ... born at term. , A study conducted by the University,s ... as the preterm child experiences no brain injury in early ... as good as their term-born peers. , However, the results ...
(Date:7/29/2014)... is a rare disease it affects 1 in 100,000 ... the esophageal wall. While its cause remains unknown, a new ... Belgium, the University of Bonn in Germany and other European ... in origin. The study, published on 6 July in ... mysterious disease. , When we swallow, a sphincter in the ...
Breaking Biology News(10 mins):23andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 3Preterm children's brains can catch up years later 2Mysterious esophagus disease is autoimmune after all 2
... COLLEGE PARK, MD, April 7, 2009 -- Roughly 20 ... light homes, businesses, and other private and public spaces. ... it also presents a tremendous opportunity for savings. Improving ... a little -- could translate into dramatically lower energy ...
... the humble baker,s yeast has revealed surprising variation in ... as nature,s oldest clock. In a paper published in ... genes that are essential to all Earth,s organisms provide ... evolutionary journey. Ribosomal RNA sequence changes have been ...
... tiger salamanders used as live bait for freshwater fishing. ... largemouth bass, channel catfish and other freshwater fishes. ... for: salamanders in bait shops in Arizona, Colorado and ... Arizona, with a chytrid fungus called Batrachochytrium dendrobatidis (Bd). ...
Cached Biology News:Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 2Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 3Spring fishing season arrives... and with it, amphibian diseases 2Spring fishing season arrives... and with it, amphibian diseases 3
... Shakers combine high durability and performance ... The patented triple-counterbalanced heavy-duty mechanism ... run with heavy out-of-balance loads. ... contamination. The heavy stainless steel ...
... System features Saga GT , is an ... electrophoresis, lane finding, location of standards, calibration ... GT is second generation software developed ... developed at the University of Washington and ...
... BioPrime Plus Array CGH Genomic Labeling Systems ... reproducible labeling of genomic DNA samples for ... both indirect and direct labeling formats, the ... provide a flexible solution to your genomic ...
Request Info...
Biology Products: